Enterprise League logo

Product

Myc Degraders

BIOTECHNOLOGY

byTen63 Therapeutics

United States (US)

ABOUT THE PRODUCT

A novel therapeutic approach targeting Myc, a key driver of cancer development. These degraders eliminate Myc from cancer cells and the surrounding microenvironment, unleashing the immune system against notoriously hard-to-treat cancers.

Information is owner-confirmed

Last updated 2 weeks ago

Price range
N/A

Other products/services from Ten63 Therapeutics